Aspercreme Lidocaine No-Mess Bergamot Orange

Manufacturer
Chattem, Inc.
Effective date
2023-10-25
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
legacy-cache
Hydrated at
2026-08-01 21:23:41

Label at a glance#

ProductAspercreme Lidocaine No-Mess Bergamot Orange
Active ingredientLIDOCAINE HYDROCHLORIDE
Label structure8 sections

Dosage and administration

a dults and children over 12 years: ■ apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period children 12 years or younger : ask a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

ASPERCREME LIDOCAINE WITH BERGAMOT NO-MESS

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Lidocaine HCl 4%

Purpose

OTC - PURPOSE SECTION

Topical anesthetic

Use  

INDICATIONS & USAGE SECTION

temporarily relieves minor pain

Warnings

WARNINGS SECTION

For external use only

Do not use 

OTC - DO NOT USE SECTION

■ on large areas of the body or on cut, irritated or swollen skin

■ on puncture wounds 

■ for more than one week without consulting a doctor 

When using this product

OTC - WHEN USING SECTION

■ use only as directed. Read and follow all directions and warnings on this carton.

■ do not allow contact with the eyes and mucous membranes

■ do not bandage or apply local heat (such as heating pads) or a medicated patch to the area of use

■ do not use at the same time as other topical analgesics  

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ condition worsens

■ redness is present

■ irritation develops

■ symptoms persist for more than 7 days or clear up and occur again within a few days

Flammable  ■ Keep away from fire or flame

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children over 12 years:

■ apply a thin layer to affected area every 6 to 8 hours, not to exceed 3 applications in a 24 hour period

children 12 years or younger: ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, citrus aurantium bergamia (bergamot) fruit oil, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, isohexadecane, methylparaben, polysorbate 60, steareth-2, steareth-21, water

Child-resistant packaging. Close cap tightly after use.

Keep carton as it contains important information.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAX STRENGTH
Aspercreme

WITH 4% LIDOCAINE
infused with ESSENTIAL OIL

2.5 fl oz (73 mL)

Principal Display Panel NEW MAX STRENGTH Aspercreme WITH 4% LIDOCAINE infused with ESSENTIAL OIL 2.5 fl oz (73 mL)Principal Display Panel NEW MAX STRENGTH Aspercreme WITH 4% LIDOCAINE infused with ESSENTIAL OIL 2.5 fl oz (73 mL)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41167-059041167-0590-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 21 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
061b4c6b-4f08-4c53-8cf1-9cd995afe3785aac1c7b-6839-4f08-8192-ddc586fd47852024-11-11WarningsExact identifier
spl set id: 5aac1c7b-6839-4f08-8192-ddc586fd4785

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.